Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce
Nov 12
Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies9
- 7D-5.8%
- 3M33.8%
- 1Y-28.3%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 9.3%, driven by declines from every company within the industry. However, the industry is down 29% over the past year. As for the next few years, earnings are expected to grow by 24% per annum.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | CN¥90.8b | CN¥121.0b | CN¥3.9b | 20.4x | 23.3x | 0.8x |
| Sat, 19 Oct 2024 | CN¥81.6b | CN¥119.6b | CN¥4.3b | 18.3x | 18.9x | 0.7x |
| Mon, 16 Sep 2024 | CN¥66.6b | CN¥119.6b | CN¥4.3b | 15.3x | 15.4x | 0.6x |
| Wed, 14 Aug 2024 | CN¥74.9b | CN¥118.4b | CN¥4.8b | 17.5x | 15.6x | 0.6x |
| Fri, 12 Jul 2024 | CN¥80.7b | CN¥118.4b | CN¥4.8b | 19.1x | 16.8x | 0.7x |
| Sun, 09 Jun 2024 | CN¥113.7b | CN¥118.4b | CN¥4.8b | 24.8x | 23.7x | 1x |
| Tue, 07 May 2024 | CN¥126.3b | CN¥118.1b | CN¥4.8b | 26.6x | 26.1x | 1.1x |
| Thu, 04 Apr 2024 | CN¥116.0b | CN¥114.8b | CN¥5.2b | 21.5x | 22.2x | 1x |
| Sat, 02 Mar 2024 | CN¥117.5b | CN¥115.9b | CN¥5.8b | 20.7x | 20.2x | 1x |
| Mon, 29 Jan 2024 | CN¥119.4b | CN¥116.0b | CN¥5.7b | 21x | 20.8x | 1x |
| Wed, 27 Dec 2023 | CN¥124.7b | CN¥116.0b | CN¥5.7b | 21.5x | 21.7x | 1.1x |
| Fri, 24 Nov 2023 | CN¥127.5b | CN¥116.0b | CN¥5.7b | 22.6x | 22.2x | 1.1x |
| Sun, 22 Oct 2023 | CN¥110.3b | CN¥113.6b | CN¥5.7b | 21.3x | 19.4x | 1x |
| Tue, 19 Sep 2023 | CN¥121.9b | CN¥113.6b | CN¥5.7b | 24x | 21.5x | 1.1x |
| Thu, 17 Aug 2023 | CN¥136.0b | CN¥109.7b | CN¥5.4b | 28.8x | 25x | 1.2x |
| Sat, 15 Jul 2023 | CN¥127.1b | CN¥109.7b | CN¥5.4b | 26.9x | 23.4x | 1.2x |
| Mon, 12 Jun 2023 | CN¥127.9b | CN¥109.7b | CN¥5.4b | 26.4x | 23.5x | 1.2x |
| Wed, 10 May 2023 | CN¥132.8b | CN¥109.2b | CN¥5.4b | 27.4x | 24.6x | 1.2x |
| Fri, 07 Apr 2023 | CN¥146.0b | CN¥94.8b | CN¥4.4b | 38.9x | 33.5x | 1.5x |
| Sun, 05 Mar 2023 | CN¥141.9b | CN¥90.3b | CN¥4.0b | 35.3x | 35.3x | 1.6x |
| Tue, 31 Jan 2023 | CN¥139.2b | CN¥90.3b | CN¥4.0b | 35.6x | 34.6x | 1.5x |
| Thu, 29 Dec 2022 | CN¥137.0b | CN¥90.3b | CN¥4.0b | 34.7x | 34x | 1.5x |
| Sat, 26 Nov 2022 | CN¥147.0b | CN¥90.3b | CN¥4.0b | 37.5x | 36.5x | 1.6x |
| Mon, 24 Oct 2022 | CN¥129.1b | CN¥85.6b | CN¥3.8b | 40.5x | 33.8x | 1.5x |
| Wed, 21 Sep 2022 | CN¥109.9b | CN¥85.6b | CN¥3.8b | 34.5x | 28.8x | 1.3x |
| Fri, 19 Aug 2022 | CN¥112.9b | CN¥80.8b | CN¥3.7b | 35.7x | 30.3x | 1.4x |
| Sun, 17 Jul 2022 | CN¥115.2b | CN¥80.8b | CN¥3.7b | 37.9x | 30.9x | 1.4x |
| Tue, 14 Jun 2022 | CN¥108.0b | CN¥80.8b | CN¥3.7b | 34.9x | 28.9x | 1.3x |
| Thu, 12 May 2022 | CN¥95.5b | CN¥80.8b | CN¥3.7b | 29.1x | 25.6x | 1.2x |
| Sat, 09 Apr 2022 | CN¥95.0b | CN¥75.3b | CN¥4.1b | 26.2x | 23.4x | 1.3x |
| Mon, 07 Mar 2022 | CN¥119.1b | CN¥74.7b | CN¥4.1b | 33.6x | 29.2x | 1.6x |
| Wed, 02 Feb 2022 | CN¥118.6b | CN¥74.7b | CN¥4.1b | 34.3x | 29.1x | 1.6x |
| Fri, 31 Dec 2021 | CN¥130.8b | CN¥74.7b | CN¥4.1b | 36.5x | 32.1x | 1.8x |
| Sun, 28 Nov 2021 | CN¥126.0b | CN¥74.7b | CN¥4.1b | 33.1x | 30.9x | 1.7x |
Price to Earnings Ratio
30.9x
Current Industry PE
- Investors are pessimistic on the Chinese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.1x which is lower than its 3-year average PE of 26.3x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.75x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | -3.39% | |
| Consumer Staples | -3.12% | |
| Food and Staples Retail | -3.90% | |
| Drug Retail | -5.79% | |
| Food Distributors | -1.95% | |
| Food Retail | -2.79% | |
| Big Box Super Stores | -3.18% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 605266 Jianzhijia Pharmaceutical Chain Group | CN¥27.78 | 4.8% +CN¥200.5m | -43.3% | PE18.4x |
